Piromidic Acid Gram-negative antimicrobial

Piromidic Acid (CAS 19562-30-2)

Piromidic Acid | CAS 19562-30-2 is rated 5.0 out of 5 by 1.
  • y_2019, m_4, d_19, h_3
  • bvseo_bulk, prod_bvrr, vn_bulk_2.0.12
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_296098, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 86ms
  • REVIEWS, PRODUCT
Synonym: Bactramyl; Enterol; Panacid
Application: Gram-negative antimicrobial
CAS Number: 19562-30-2
Purity: >99%
Molecular Weight: 288.30
Molecular Formula: C14H16N4O3
* Refer to Certificate of Analysis for lot specific data (including water content).
Submit a review for this product and receive 15 CruzCredits

Piromidic Acid is shown to have antibacterial properties against gram-negative bacteria.


References

1. Mahmoudi, N. et al. 2003. Antimicrob. Agents Chemother. 47(8): 2636-2639. PMID: 12878530

Appearance :
Powder
Physical State :
Solid
Solubility :
Soluble in water (partly miscible), ethanol, and chloroform.
Storage :
Store at 4° C
Melting Point :
314° C
Boiling Point :
504° C at 760 mmHg
Density :
1.4 g/cm3
Refractive Index :
n20D ~1.63 (Predicted)
IC50 :
HeLa: IC50 = 97 µM (human); HepG2: IC50 = 110 µM (human); DNA gyrase : IC50 = >100 ug.mL-1 (Escherichia coli K-12)
pK Values :
pKa: 3.27 (Predicted), pKb: 6.54 (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
RTECS :
UV1153900
PubChem CID :
4855
EC Number :
243-161-4
SMILES :
CCN1C=C(C(=O)C2=CN=C(N=C21)N3CCCC3)C(=O)O

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

Piromidic Acid  Product Citations

See how others have used Piromidic Acid. Click on the entry to view the PubMed entry .

Citations 1 to 1 of 1 total

PMID: # 23136016  Lohne, JJ. et al. 2012. Rapid Commun. Mass Spectrom. 26: 2854-64.

Citations 1 to 1 of 1 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 54ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Mahmoudi N; et al Mahmoudi N; et al. (PubMed ID: 12878530) determined that Piromidic Acid decreased the hepatic stages of P. falciparum and P. yoelii yoelii. -SCBT Publication Review
Date published: 2015-07-13
  • y_2019, m_4, d_19, h_3
  • bvseo_bulk, prod_bvrr, vn_bulk_2.0.12
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_296098, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 33ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.